The use of antiprotozoan and anthelmintic drugs during pregnancy and contraindications.
Horton
J
J
D015766:Albendazole / Q000009:adverse effects*; D000962:Antimalarials / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009153:Mutagens / Q000009:adverse effects; D010616:Phenanthrenes / Q000009:adverse effects*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy*; D013723:Teratogens
D000962:Antimalarials; D009153:Mutagens; D010616:Phenanthrenes; D013723:Teratogens; D015766:Albendazole; C023768:halofantrine